英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
prodigere查看　prodigere　在百度字典中的解释百度英翻中〔查看〕
prodigere查看　prodigere　在Google字典中的解释Google英翻中〔查看〕
prodigere查看　prodigere　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Tempus | AI-Powered Precision Medicine Genomic Testing
    Tempus has built the world’s largest library of clinical molecular data and an operating system to make that data accessible and useful, starting with cancer
  • Investor Relations | Tempus AI
    The Investor Relations website contains information about Tempus AI's business for stockholders, potential investors, and financial analysts
  • Tempus Announces the Launch of Paige Predict | Tempus AI
    Leveraging Tempus and Paige’s intelligent digital pathology platform and proprietary AI products, Paige Predict identifies critical biomarker information from even scarce amounts of tissue and analyzes H E images to predict the likelihood of 123 biomarkers and oncogenic molecular pathways in 16 cancer types, including NSCLC, prostate, breast
  • Press Releases | News | Tempus
    Tempus AI, Inc (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Merck, known as MSD outside of the United States and Canada, today announced an expanded, multi-year collaboration aimed at accelerating the discovery and development of precision medicine biomarkers and supporting Merck
  • Our Technology | AI Platforms for Precision Medicine | Tempus
    Tempus is bringing data and AI to healthcare We’re building innovative tech solutions oriented around clinical care and research products Tempus is bringing data and AI to healthcare We’re building innovative tech solutions oriented around clinical care and research products
  • Tempus AI
    Tempus AI
  • Stock Quote Chart - Tempus AI
    The Investor Relations website contains information about Tempus AI's business for stockholders, potential investors, and financial analysts
  • Tempus Announces Strategic Collaboration Agreement with Merck to . . .
    Tempus AI, Inc (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Merck, known as MSD outside of the United States and Canada, today announced an expanded, multi-year collaboration aimed at accelerating the discovery and development of precision medicine biomarkers and supporting Merck’s oncology and potentially broader therapeutic portfolios
  • Tempus Reports First Quarter 2025 Results | Tempus AI
    CHICAGO -- (BUSINESS WIRE)--May 6, 2025-- Tempus AI, Inc (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financial results for the quarter ended March 31, 2025 Revenue increased 75 4% year-over-year to $255 7 million in the first quarter of 2025 Quarterly gross profit increased 99 8% year-over-year, reaching $155 2
  • AI in Healthcare in 2026 and Beyond - tempus. com
    Discover how Tempus utilizes generative AI, large-scale multimodal datasets, and advanced pathology models to accelerate drug discovery and close care gaps in oncology





中文字典-英文字典  2005-2009